Fairvalue-Calculator Fairvalue-Calculator
EN DE

SANUWAVE Health, Inc (SNWV) Fair Value & Analysis

Healthcare · US · Market cap $77.5M

Price$8.20
Fair Value$8.86
Upside+8.0%
Quality95/100
Evidence: High Range $6.32 – $11.39

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

SANUWAVE Health, Inc (SNWV) currently trades at $8.20, while our model-based Fair Value estimate is $8.86 — implying the stock looks roughly 8.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is SANUWAVE Health, Inc (SNWV) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $8.86 versus a price of $8.20 — about +8% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SNWV?
Our 21-model fair value for SANUWAVE Health, Inc is $8.86 (as of Jun 24, 2026), built from audited fundamentals. The current price is $8.20.
What is the quality score of SNWV?
SANUWAVE Health, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.